These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34628685)

  • 1. Implementing a regional standardized BK polyomavirus screening protocol across eleven transplant centres.
    Rogers R; Bodziak K; Cheema F; Chobanian M; Ebcioglu Z; Gabardi S; Ghai S; Gilligan H; Gohh R; Goyal N; Kavalam G; Mehri B; Rodig N; Rossi A; Singh J; Wood E; Tan CS; Pavlakis M
    Transpl Int; 2021 Dec; 34(12):2680-2685. PubMed ID: 34628685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
    Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and outcomes of late-onset BK virus nephropathy in kidney and kidney-pancreas transplant recipients.
    Imlay H; Whitaker K; Fisher CE; Limaye AP
    Transpl Infect Dis; 2018 Aug; 20(4):e12928. PubMed ID: 29809315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine Donor-Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection.
    Chen XT; Chen WF; Li J; Deng RH; Huang Y; Yang SC; Chen PS; Jiang TY; Liu HT; Wang CX; Chen LZ; Qiu J; Huang G
    Front Immunol; 2020; 11():1763. PubMed ID: 32973745
    [No Abstract]   [Full Text] [Related]  

  • 5. New England BK consortium: Regional survey of BK screening and management protocols in comparison to published consensus guidelines.
    Gabardi S; Pavlakis M; Tan C; Francis J; Cardarelli F; Asch W; Bodziak K; Chobanian M; Gilligan H; Gohh R; Kung SC; Inker L; Martin S; Rodig N; Rossi A; Chandraker A
    Transpl Infect Dis; 2018 Dec; 20(6):e12985. PubMed ID: 30175491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of BK polyomavirus genotypes to predict the development of BK polyomavirus-associated complications in kidney transplant recipients: A retrospective analysis.
    Muñoz-Gallego I; Díaz-Madridano N; Moral N; Pascual C; Polanco N; González E; Andrés A; Folgueira MD
    Transpl Infect Dis; 2021 Aug; 23(4):e13615. PubMed ID: 33866657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
    Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
    Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of polyoma BK virus infection among living-donor renal transplant recipients.
    El Ansary M; Abd Elhamid S; Saadi G; Ismail W; Ibrahim N; Bahaa El-Din N; Alhsyek S
    Transpl Infect Dis; 2016 Aug; 18(4):529-37. PubMed ID: 27226063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
    Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
    Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor.
    Lorentzen EM; Henriksen S; Kaur A; Kro GB; Hammarström C; Hirsch HH; Midtvedt K; Rinaldo CH
    Virol J; 2020 Jan; 17(1):5. PubMed ID: 31924245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urothelial cell carcinoma after BK polyomavirus infection in kidney transplant recipients: A cohort study of veterans.
    Rogers R; Gohh R; Noska A
    Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28727230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostics, treatment, and immune response in BK polyomavirus infection after pediatric kidney transplantation.
    Ahlenstiel-Grunow T; Pape L
    Pediatr Nephrol; 2020 Mar; 35(3):375-382. PubMed ID: 30539254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BK polyomavirus in kidney transplant recipients: screening, monitoring and clinical management.
    Varella RB; Almeida JR; Lopes Pde F; Matos JP; Menezes P; Lugon JR
    J Bras Nefrol; 2014; 36(4):529-34. PubMed ID: 25517283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyoma BK Virus in Kidney Transplant Recipients: Screening, Monitoring, and Management.
    Myint TM; Chong CHY; Wyld M; Nankivell B; Kable K; Wong G
    Transplantation; 2022 Jan; 106(1):e76-e89. PubMed ID: 33908382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia.
    Gabardi S; Ramasamy S; Kim M; Klasek R; Carter D; Mackenzie MR; Chandraker A; Tan CS
    Transpl Infect Dis; 2015 Aug; 17(4):536-43. PubMed ID: 25989423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BK DNAemia and native kidney polyomavirus nephropathy following lung transplantation.
    Dube GK; Batal I; Shah L; Robbins H; Arcasoy SM; Husain SA
    Am J Transplant; 2023 Feb; 23(2):284-290. PubMed ID: 36804135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BK Polyomavirus-specific T Cells as a Diagnostic and Prognostic Marker for BK Polyomavirus Infections After Pediatric Kidney Transplantation.
    Ahlenstiel-Grunow T; Sester M; Sester U; Hirsch HH; Pape L
    Transplantation; 2020 Nov; 104(11):2393-2402. PubMed ID: 31985731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation: long-term outcomes.
    Bischof N; Hirsch HH; Wehmeier C; Amico P; Dickenmann M; Hirt-Minkowski P; Steiger J; Menter T; Helmut H; Schaub S
    Nephrol Dial Transplant; 2019 Jul; 34(7):1240-1250. PubMed ID: 30476254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of BK viremia by urine viral load in renal transplant patients: An analysis of BK viral load results in paired urine and plasma samples.
    Madden K; Janitell C; Sower D; Yang S
    Transpl Infect Dis; 2018 Oct; 20(5):e12952. PubMed ID: 29896858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IVIg therapy in the management of BK virus infections in pediatric kidney transplant patients.
    Mosca M; Bacchetta J; Chamouard V; Rascle P; Dubois V; Paul S; Mekki Y; Picard C; Bertholet-Thomas A; Ranchin B; Sellier-Leclerc AL
    Arch Pediatr; 2023 Apr; 30(3):165-171. PubMed ID: 36907728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.